DE69518229D1 - Hustenhemmende zusammensetzung die ein antitussivum und benzydamin enthält - Google Patents

Hustenhemmende zusammensetzung die ein antitussivum und benzydamin enthält

Info

Publication number
DE69518229D1
DE69518229D1 DE69518229T DE69518229T DE69518229D1 DE 69518229 D1 DE69518229 D1 DE 69518229D1 DE 69518229 T DE69518229 T DE 69518229T DE 69518229 T DE69518229 T DE 69518229T DE 69518229 D1 DE69518229 D1 DE 69518229D1
Authority
DE
Germany
Prior art keywords
pct
antitussive
benzydamine
cough
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69518229T
Other languages
English (en)
Other versions
DE69518229T2 (de
Inventor
Angeli Depalmo Galli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of DE69518229D1 publication Critical patent/DE69518229D1/de
Publication of DE69518229T2 publication Critical patent/DE69518229T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE69518229T 1994-03-01 1995-02-22 Hustenhemmende zusammensetzung die ein antitussivum und benzydamin enthält Expired - Fee Related DE69518229T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI940362A IT1274026B (it) 1994-03-01 1994-03-01 Composizione antitosse
PCT/EP1995/000658 WO1995023602A1 (en) 1994-03-01 1995-02-22 Antitussive composition containing an antitussive and benzydamine

Publications (2)

Publication Number Publication Date
DE69518229D1 true DE69518229D1 (de) 2000-09-07
DE69518229T2 DE69518229T2 (de) 2001-03-08

Family

ID=11368015

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69518229T Expired - Fee Related DE69518229T2 (de) 1994-03-01 1995-02-22 Hustenhemmende zusammensetzung die ein antitussivum und benzydamin enthält

Country Status (27)

Country Link
US (1) US5932589A (de)
EP (1) EP0748222B1 (de)
JP (1) JP3348858B2 (de)
KR (1) KR970701047A (de)
CN (1) CN1088358C (de)
AT (1) ATE195074T1 (de)
AU (1) AU681257B2 (de)
BR (1) BR9506956A (de)
CA (1) CA2184594C (de)
CZ (1) CZ284798B6 (de)
DE (1) DE69518229T2 (de)
DK (1) DK0748222T3 (de)
ES (1) ES2149969T3 (de)
FI (1) FI963394A0 (de)
GR (1) GR3034665T3 (de)
HU (1) HUT75937A (de)
IT (1) IT1274026B (de)
NO (1) NO309965B1 (de)
NZ (1) NZ281230A (de)
PL (1) PL178608B1 (de)
PT (1) PT748222E (de)
RO (1) RO117147B1 (de)
RU (1) RU2143901C1 (de)
SK (1) SK282567B6 (de)
UA (1) UA37278C2 (de)
WO (1) WO1995023602A1 (de)
ZA (1) ZA951588B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124282A (en) * 1997-05-22 2000-09-26 Sellers; Edward M. Drug formulations
CA2314893C (en) * 1997-12-22 2005-09-13 Euro-Celtique, S.A. Opioid agonist/antagonist combinations
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
WO2003089007A1 (en) * 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
ES2343641T3 (es) * 2005-01-14 2010-08-05 Camurus Ab Formulaciones bioadhesivas topicas.
EP1848403B8 (de) * 2005-01-14 2010-05-19 Camurus Ab Topische bioadhäsive formulierungen
CN101219140B (zh) * 2007-12-24 2011-06-01 重庆市莱美药物技术有限公司 盐酸苄达明可溶片及其制备方法
CN102470125B (zh) 2009-07-08 2015-08-19 方济各安吉利克化学联合股份有限公司 苄达明在制备治疗p40-依赖性疾病的药物中的用途
EP2968151B1 (de) * 2013-03-13 2017-04-19 Tris Pharma, Inc. Feste benzonatattabletten und kapseln mit modifizierter freisetzung
CN107873024A (zh) * 2015-02-09 2018-04-03 塞尔利克斯生物私人有限公司 用于治疗粘膜炎的组合物和方法
US11214544B2 (en) 2017-04-14 2022-01-04 Kempharm, Inc. Dextrorphan prodrugs and processes for making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
CA2129676C (en) * 1990-10-31 1997-09-30 Ronald Lee Smith Dextromethorphan antitussive compositions

Also Published As

Publication number Publication date
PL316079A1 (en) 1996-12-23
FI963394A (fi) 1996-08-30
CZ284798B6 (cs) 1999-03-17
AU681257B2 (en) 1997-08-21
EP0748222A1 (de) 1996-12-18
EP0748222B1 (de) 2000-08-02
CA2184594C (en) 2002-09-17
CZ253296A3 (en) 1997-01-15
CN1088358C (zh) 2002-07-31
NO963634L (no) 1996-08-30
ITMI940362A1 (it) 1995-09-01
CN1143909A (zh) 1997-02-26
ES2149969T3 (es) 2000-11-16
PL178608B1 (pl) 2000-05-31
FI963394A0 (fi) 1996-08-30
SK282567B6 (sk) 2002-10-08
ATE195074T1 (de) 2000-08-15
JPH09509670A (ja) 1997-09-30
HUT75937A (en) 1997-05-28
DE69518229T2 (de) 2001-03-08
ZA951588B (en) 1995-12-08
UA37278C2 (uk) 2001-05-15
RU2143901C1 (ru) 2000-01-10
HU9602390D0 (en) 1996-10-28
ITMI940362A0 (it) 1994-03-01
WO1995023602A1 (en) 1995-09-08
AU1811695A (en) 1995-09-18
SK108596A3 (en) 1997-04-09
PT748222E (pt) 2001-01-31
RO117147B1 (ro) 2001-11-30
US5932589A (en) 1999-08-03
BR9506956A (pt) 1997-09-16
JP3348858B2 (ja) 2002-11-20
KR970701047A (ko) 1997-03-17
GR3034665T3 (en) 2001-01-31
MX9603747A (es) 1997-12-31
NO963634D0 (no) 1996-08-30
DK0748222T3 (da) 2000-12-18
NO309965B1 (no) 2001-04-30
NZ281230A (en) 1998-04-27
CA2184594A1 (en) 1995-09-08
IT1274026B (it) 1997-07-14

Similar Documents

Publication Publication Date Title
NO960067D0 (no) Nytt farmasöytisk preparat
DE69518229T2 (de) Hustenhemmende zusammensetzung die ein antitussivum und benzydamin enthält
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
IS4174A (is) Ný notkun á lyfjafræðilega viðurkenndu salti
AU6519596A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
JO1821B1 (en) New pharmaceutical product

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee